「to」の検索結果
406件：366～370件目を表示
-
ment of Dry Eye Disease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; ...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322_0.pdf -
Overseas Activities | SENJU Pharmaceutical
h and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the er...
https://www.senju.co.jp/english/global/ -
Overseas Activities | SENJU Pharmaceutical
h and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the er...
http://www.senju.co.jp/english/global/ -
ment of Dry Eye Disease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; ...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322.pdf -
Business Activities | About Senju | SENJU Pharmaceutical
Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph...
http://www.senju.co.jp/english/about/business/